Authors

Frédéric Blais, PhD

Director, Central Monitoring, CluePoints

Latest Article

KRI Overload: When More Isn’t Better

To maximize the impact of signal detection, KRI frameworks should follow a few guiding principles.

Jill Bell
Latest Article

Investigative Site Investment, Preparedness, and Experience with Digital Solutions

A new global Tufts CSDD survey of 387 investigative site professionals reveals broad experience with digital and decentralized trial tools, growing site-driven technology investments, and strong support for remote data collection—while highlighting persistent burdens tied to fragmented systems, training demands, and financial strain.

Allison Cuff Shimooka

Chief Operating Officer, TransCelerate BioPharma

Latest Article

Science is Moving—Clinical Trials Must Catch Up

The importance of applying past lessons to align clinical development with scientific advancement.

Victoria Sherlock

Special Counsel, Tax Controversy and Litigation Practice, Chamberlain Hrdlicka


Latest Article

The Federal Research Credit: Is It Worth All the Trouble?

The key considerations for sponsors in deciding whether to claim the credit.

Beth Anderson
Beth Anderson

CEO of Arkitek Scientific

Latest Article

Animated Explainers Can Be Game-Changers in Cohort Recruitment

By using engaging visuals, researchers and companies can better communicate complex concepts, increase trial participation, and foster public trust in science.

AICure
Latest Article

AiCure Overview Fact Sheet

Modern clinical trials can be an overwhelming experience for participants, compromising everything from medication adherence and data quality to overall study outcomes. AiCure’s H.Code is a patient engagement platform that reinvents the clinical trial experience for participants using cutting-edge AI, easy communication, and dedicated support for sites. Read our fact sheet to learn how H.Code extends the reach of your clinical team using an AI-powered analytics platform and a user-friendly smartphone app.

Zahiah (Zee Zee) Gueddar

Senior Director, Commercialization, IQVIA Technologies

Latest Article

Notable Discussions from SCOPE 2025: Aiming to Calculate, Accommodate, and Innovate for Enhanced Drug Development

This year’s conference highlighted a number of critical areas in clinical R&D including financial management, representation, and eCOA.

Beth Harper, MBA

Project Manager, Senior Research Consultant with Tufts Center for the Study of Drug Development (Tufts CSDD)

Latest Article

Benchmarking the Investigative Site Qualification Process

Insights identify opportunities to optimize sponsor, CRO, and site collaborations.

Mandis Beigi

Senior Director, Medidata Solutions

Latest Article

Accelerating Breakthroughs with Synthetic Clinical Trial Data

The emergence of AI-powered simulants in improving study efficiency.

Melissa Mooney

Director Solution Engineering, IQVIA Patient Suite, IQVIA Technologies

Latest Article

Notable Discussions from SCOPE 2025: Aiming to Calculate, Accommodate, and Innovate for Enhanced Drug Development

This year’s conference highlighted a number of critical areas in clinical R&D including financial management, representation, and eCOA.